Quintet Private Bank (Europe) S.A. Recursion Pharmaceuticals, Inc. Transaction History
Quintet Private Bank (Europe) S.A.
- $1.78 Trillion
- Q3 2025
A detailed history of Quintet Private Bank (Europe) S.A. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Quintet Private Bank (Europe) S.A. holds 2,000 shares of RXRX stock, worth $12,180. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000Holding current value
$12,180% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
367Shares Held
288MCall Options Held
7.76MPut Options Held
6.19M-
Vanguard Group Inc Valley Forge, PA36.1MShares$220 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33MShares$201 Million1.38% of portfolio
-
Baillie Gifford & CO24.2MShares$147 Million0.1% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$105 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$89.3 Million0.31% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.1B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...